Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

Share Price is delayed by 15 minutes
Get Live Data
4,401.50    117.00 (2.73%)
Bid:
4,382.00
Ask:
4,383.50
Spread: 1.50 (0.034%)
Market Cap: £95.31b
ULVR Live PriceLast checked at - London Stock Exchange

Intraday Unilever Share Chart

Director Declaration

2 Nov 2021 16:40

RNS Number : 1188R
Unilever PLC
02 November 2021
Β 

Unilever PLC

Director Declaration

Β 

Β 

In accordance with Listing Rule 9.6.14, Unilever PLC announces that Adrian Hennah, an Independent Non-Executive Director whose appointment took effect from 1 November 2021, is a Non-Executive Director of Oxford Nanopore Technologies plc, a company admitted to trading on the London Stock Exchange, effective 5 October 2021.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RDNDKBBNABDDCDK
Date   Source Headline
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20254:35 pmRNSDirector/PDMR Shareholding
11th Mar 20251:57 pmRNS2025-03-11 ULE Award Grants
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20254:36 pmRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSDirectorate Change
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20251:14 pmRNSDirector/PDMR Shareholding Amendment
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20255:00 pmRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20253:35 pmRNSPublication of Supplement
13th Feb 20257:00 amRNSShare Buy-Back Programme
13th Feb 20257:00 amRNSFinal Results
5th Feb 20259:58 amRNSDirectorate Change
3rd Feb 20254:19 pmRNSTotal Voting Rights
16th Jan 202511:27 amRNSDirector Declaration
2nd Jan 20252:34 pmRNSTotal Voting Rights
13th Dec 20243:42 pmRNSDirector/PDMR Shareholding
11th Dec 20244:07 pmRNSDirector/PDMR Shareholding
10th Dec 20249:50 amRNSDirector/PDMR Shareholding
9th Dec 20241:00 pmRNSULE Organisational Changes
2nd Dec 20242:55 pmRNSTotal Voting Rights
28th Nov 20244:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20241:00 pmRNSUnilever Investor Event
11th Nov 202412:30 pmRNSDirector/PDMR Shareholding
5th Nov 20245:27 pmRNSCompletion of 2024 Share Buyback
5th Nov 20245:00 pmRNSTransaction in Own Shares
4th Nov 20245:21 pmRNSTransaction in Own Shares
1st Nov 20242:14 pmRNSTotal Voting Rights
31st Oct 20245:15 pmRNSTransaction in Own Shares
31st Oct 202411:17 amRNSDirector/PDMR Shareholding
31st Oct 202411:15 amRNSDirector/PDMR Shareholding
30th Oct 20245:15 pmRNSTransaction in Own Shares
29th Oct 20245:12 pmRNSTransaction in Own Shares
28th Oct 20245:14 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.